James F. Howard Jr.

The expanding treatment landscape for myasthenia gravis 2:11
The expanding treatment landscape for myasthenia gravis
James F. Howard Jr. • 7 Apr 2021
REGAIN study and extension trial of eculizumab in myasthenia gravis 1:34
REGAIN study and extension trial of eculizumab in myasthenia gravis
James F. Howard Jr. • 7 Apr 2021
Concomitant immunosuppressive therapy in gMG patients on the REGAIN extension study 1:02
Concomitant immunosuppressive therapy in gMG patients on the REGAIN extension study
James F. Howard Jr. • 7 Apr 2021
Impact of fcRn inhibitors on IgG-mediated autoimmune disorders 0:45
Impact of fcRn inhibitors on IgG-mediated autoimmune disorders
James F. Howard Jr. • 7 Apr 2021
The content of VJNeurology is intended for healthcare professionals